Merck

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
68,000
Employees68,000
Headquarters
Kenilworth, New Jersey
HeadquartersKenilworth, New Jersey
Founded
1891
Founded1891
Employees
68,000
Employees68,000

MRK Key Statistics

Market cap
270.97B
Market cap270.97B
Price-Earnings ratio
18.07
Price-Earnings ratio18.07
Dividend yield
2.58
Dividend yield2.58
Average volume
8.09M
Average volume8.09M
High today
$108.67
High today$108.67
Low today
$105.82
Low today$105.82
Open price
$108.53
Open price$108.53
Volume
9.67M
Volume9.67M
52 Week high
$115.49
52 Week high$115.49
52 Week low
$72.88
52 Week low$72.88

MRK News

Yahoo Finance 10h
Merck Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance

Wall Street expects a year-over-year decline in earnings on higher revenues when Merck (MRK) reports results for the quarter ended December 2022. While this wid...

Merck Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
Reuters 2d
Merck ends Keytruda trial in prostate cancer patients after dismal ... - Reuters

Jan 25 (Reuters) - Merck & Co Inc (MRK.N) said on Wednesday it was discontinuing a late-stage trial of its blockbuster immunotherapy Keytruda in s...

Merck ends Keytruda trial in prostate cancer patients after dismal ... - Reuters
Yahoo Finance 2d
Merck Announces Second-Quarter 2023 Dividend - Yahoo Finance

RAHWAY, N.J., January 24, 2023--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Dire...

Merck Announces Second-Quarter 2023 Dividend - Yahoo Finance

Analyst ratings

65%

of 26 ratings
Buy
65.4%
Hold
34.6%
Sell
0%

MRK Earnings

$0.00
$0.71
$1.43
$2.14
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
$1.53 per share
Estimated$1.53 per share
Actual
Available Feb 2, Pre-Market
ActualAvailable Feb 2, Pre-Market

More MRK News

Yahoo Finance 2d
Do You Think Merck & Co. is an Attractive Investment? - Yahoo Finance

Smead Capital Management, an investment management company, released its "Smead Value Fund" fourth quarter 2022 investor letter. A copy of the same can be downl...

Do You Think Merck & Co. is an Attractive Investment? - Yahoo Finance
Yahoo Finance 2d
Announcing The 2023 Franklin Institute Awards Laureates - Yahoo Finance

SOCIAL EQUITY, SUSTAINABILITY, AND SAFETY — AMONG THE NINE AREAS OF BREAKTHROUGHS AND ADVANCEMENTS BEING CELEBRATED BY THE FRANKLIN INSTITUTE IN PHILADELPHIA, A...

Announcing The 2023 Franklin Institute Awards Laureates - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.